Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

250 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies.
Musso G, Cassader M, Gambino R. Musso G, et al. Nat Rev Drug Discov. 2016 Apr;15(4):249-74. doi: 10.1038/nrd.2015.3. Epub 2016 Jan 22. Nat Rev Drug Discov. 2016. PMID: 26794269 Review.
Non-alcoholic fatty liver disease from pathogenesis to management: an update.
Musso G, Gambino R, Cassader M. Musso G, et al. Obes Rev. 2010 Jun;11(6):430-45. doi: 10.1111/j.1467-789X.2009.00657.x. Epub 2009 Oct 21. Obes Rev. 2010. PMID: 19845871 Review.
Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials.
Musso G, Cassader M, Rosina F, Gambino R. Musso G, et al. Diabetologia. 2012 Apr;55(4):885-904. doi: 10.1007/s00125-011-2446-4. Epub 2012 Jan 27. Diabetologia. 2012. PMID: 22278337 Review.
Anti-inflammatory and antioxidant effects of resveratrol in healthy smokers a randomized, double-blind, placebo-controlled, cross-over trial.
Bo S, Ciccone G, Castiglione A, Gambino R, De Michieli F, Villois P, Durazzo M, Cavallo-Perin P, Cassader M. Bo S, et al. Curr Med Chem. 2013;20(10):1323-31. doi: 10.2174/0929867311320100009. Curr Med Chem. 2013. PMID: 23298135 Clinical Trial.
Association of obstructive sleep apnoea with the presence and severity of non-alcoholic fatty liver disease. A systematic review and meta-analysis.
Musso G, Cassader M, Olivetti C, Rosina F, Carbone G, Gambino R. Musso G, et al. Obes Rev. 2013 May;14(5):417-31. doi: 10.1111/obr.12020. Epub 2013 Feb 6. Obes Rev. 2013. PMID: 23387384 Review.
Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms.
Bugianesi E, Gastaldelli A, Vanni E, Gambino R, Cassader M, Baldi S, Ponti V, Pagano G, Ferrannini E, Rizzetto M. Bugianesi E, et al. Diabetologia. 2005 Apr;48(4):634-42. doi: 10.1007/s00125-005-1682-x. Epub 2005 Mar 4. Diabetologia. 2005. PMID: 15747110
Nonalcoholic steatohepatitis versus steatosis: adipose tissue insulin resistance and dysfunctional response to fat ingestion predict liver injury and altered glucose and lipoprotein metabolism.
Musso G, Cassader M, De Michieli F, Rosina F, Orlandi F, Gambino R. Musso G, et al. Hepatology. 2012 Sep;56(3):933-42. doi: 10.1002/hep.25739. Epub 2012 Jul 3. Hepatology. 2012. PMID: 22684858
250 results
Jump to page
Feedback